The DOI matches its Crossref record; 209 of the 209 references it cites were found in a registry or an index.
Targeting the PI3K/Akt/mTOR pathway: Effective combinations and clinical considerations
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–209 of 209
Immunohistochemical localization of phosphorylated AKT in multiple myeloma
Alkan, S., & Izban, K. F. (2002) · Blood · doi:10.1182/blood-2001-01-0317 · Cited by 31
Signaling interactions of rapamycin combined with erlotinib in cervical carcinoma xenografts
Birle, D. C., & Hedley, D. W. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0504 · Cited by 29
Wang, L., Chan, J. L. ‐., & Li, W. (2007) · International Journal of Cancer · doi:10.1002/ijc.22606 · Cited by 28
Ribatti, D., Nico, B., Mangieri, D., Longo, V., Sansonno, D. E., Vacca, A., & Dammacco, F. (2007) · PubMed · doi:10.14670/hh-22.285 · Cited by 25
Tabellini, G., Tazzari, P. L., Bortul, R., Billi, A. M., Conte, R., Manzoli, L., Cocco, L., & Martelli, A. M. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.05073.x · Cited by 24
Yip-Schneider, M., Wiesenauer, C. A., & Schmidt, C. M. (2003) · Journal of Gastrointestinal Surgery · doi:10.1016/s1091-255x(02)00156-7 · Cited by 24
Masiello, D., Mohi, G., McKnight, N. C., et al. (2007) · Cancer Biology & Therapy · doi:10.4161/cbt.6.2.3588 · Cited by 22
Reis, C., Giocanti, N., Hennequin, C., Mégnin-Chanet, F., Fernet, M., Filomenko, R., Bettaı̈eb, A., Solary, É., & Favaudon, V. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0156 · Cited by 7
A phase 1 study of daily oral perifosine (P) and weekly gemcitabine (G)
Weiss, S., Nemunaitis, J. J., Diaz-Lacayo, M., Birch, R., Ebrahimi, B., Berdeaux, D. H., Allerton, J. P., Gardner, L. R., & Henderson, I. C. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.24.18_suppl.13084 · Cited by 6
Cited by
Global signatures of protein and mRNA expression levels
de Sousa Abreu, R., Penalva, L. O., Marcotte, E. M., & Vogel, C. (2009) · Molecular BioSystems · doi:10.1039/b908315d · Cited by 1,248
Role of Pro-Inflammatory Cytokines Released from Microglia in Neurodegenerative Diseases
Smith, J. A., Das, A., Ray, S. K., & Banik, N. L. (2012) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2011.10.004 · Cited by 1,165
Strategies to improve radiotherapy with targeted drugs
Begg, A. C., Stewart, F. A., & Vens, C. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3007 · Cited by 1,118
Vigneri, P., Frasca, F., Sciacca, L., Pandini, G., & Vigneri, R. (2009) · Endocrine Related Cancer · doi:10.1677/erc-09-0087 · Cited by 1,009
The PTEN–PI3K pathway: of feedbacks and cross-talks
Carracedo, A., & Pandolfi, P. P. (2008) · Oncogene · doi:10.1038/onc.2008.247 · Cited by 878
Metadata
- Authors
- LoPiccolo, J., Blumenthal, G. M., Bernstein, W. B., & Dennis, P. A.
- Venue
- Drug Resistance Updates
- Publisher
- Elsevier BV
- Published
- 2008-02
- Volume
- 11
- Issue
- 1-2
- Pages
- 32-50
- ISSN
- 1368-7646 (ISSN-L)
- OpenAlex
- W2074433596
- Cited by
- 801
- References
- 209
- FWCI
- 24.07
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.